[High-Dose Neuropeptide Y Inhibits Proliferation and Promotes Differentiation of Human Adipose-Derived Stem Cells].
Wei Wu,Pingan Hu,Fang Liang,Xiaoqin Song,Min Liu
DOI: https://doi.org/10.13423/j.cnki.cjcmi.007653
2016-01-01
Abstract:OBJECTIVETo investigate the impact of neuropeptide Y (NPY) at different concentrations on the proliferation and differentiation of human adipose-derived stem cells (hADSCs).METHODSThe hADSCs were separated and incubated with NPY at a range of concentrations 10(-6)-10(-15) mol/L. MTT assay was used to detect cell proliferation. Following the treatment of complete medium, NPY and insulin separately, cell differentiation was observed by Oil red O staining. In addition, Western blotting was performed to exam the levels of peroxisome proliferator-activated receptor-γ (PPARγ), CCAAT/enhancer binding protein alpha (C/EBPα), cell death-inducing dFF45-like effector c (Cidec) and receptor interacting protein 140 (RIP140).RESULTSMTT assay revealed that 10(-11)-10(-15) mol/L NPY stimulated the proliferation of hADSCs, while high-dose NPY (10(-6)-10(-10) mol/L) inhibited the cell proliferation. NPY (10(-7), 10(-9), 10(-11) mol/L) induced the differentiation of hADSCs. The expression levels of related adipocyte markers (PPARγ, C/EBPα), mature white adipose tissue specific markers (Cidec, RIP140) increased at the presence of NPY (10(-7), 10(-9), 10(-11) mol/L).CONCLUSIONLow-dose NPY could stimulate the proliferation of hADSCs, and high-dose NPY could inhibit the proliferation and promote the differentiation of hADSCs.
What problem does this paper attempt to address?